Paratek Pharmaceuticals, Inc.

King of Prussia, PA

UEI
D5KEFN62CJ97
CAGE
80ES6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Parking lot, 1000 1st Ave #200, King of Prussia, PA 19406, USA
Founded
1996
Employees
251-1K
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $17,471,250
FY2025 $4,958,461
FY2024 $18,279,236
FY2023 $36,398,440

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $17,471,250

Contract vehicles

Contract awards

Quick answers

Is Paratek Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Paratek Pharmaceuticals, Inc.'s SAM.gov registration is active through July 13, 2027.

What is Paratek Pharmaceuticals, Inc.'s CAGE code?

Paratek Pharmaceuticals, Inc.'s CAGE code is 80ES6, and its Unique Entity ID (UEI) is D5KEFN62CJ97.

Which contract vehicles does Paratek Pharmaceuticals, Inc. hold?

Paratek Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

How much has Paratek Pharmaceuticals, Inc. received in federal contracts?

Federal contracts obligated $4,958,461 to Paratek Pharmaceuticals, Inc. in fiscal year 2025 and $77,107,387 in fiscal years 2023 through 2027.

How does Paratek Pharmaceuticals, Inc. rank among federal contractors?

Paratek Pharmaceuticals, Inc. ranked #45 in PSC 6505 and #70 in NAICS 541714 in FY2025.

What is Paratek Pharmaceuticals, Inc.'s most recent federal award?

Paratek Pharmaceuticals, Inc.'s most recent federal contract award is Antibiotic for treatment of a biothreat indication (75A50120C00001), from Office of the Assistant Secretary for Preparedness and Response, on December 18, 2019.

On GovTribe

See Paratek Pharmaceuticals, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe